USPTO serial 90232660
V
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DERBY, KAREN SHEREE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with V?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Laura Miller
Laura Miller KILPATRICK TOWNSEND & STOCKTON LLP1001 W. FOURTH STREETWINSTON-SALEM, NC 27101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Wearable computers in the nature of smartwatches; Wearable computers in the nature of smartglasses; Downloadable computer software for collecting, processing, analyzing, transmitting, validating and displaying data in the medical, scientific and pharmaceutical fields; Downloadable computer software for the monitoring of health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use with medical clinical trials; downloadable software used to manage clinical trials; computer hardware and recorded software for medical imaging apparatus used for capturing, visualizing, analyzing, characterizing, diagnosing and displaying anatomical, cell and tissue image data; Downloadable clinical trial data collection, storage and analysis software; data processing equipment; Downloadable computer software used for collecting, storing, analyzing, processing and displaying surgical images, videos, procedures and other surgical data; Downloadable computer software and computer programs for transmission of medical and scientific data and information; contact lenses | ACTIVE | — |
| 010 | Surgical instruments and apparatus; medical instruments and apparatus, namely, medical apparatus for diagnosis and detection of cardiovascular disease; medical apparatus for monitoring vital signs; apparatus and instruments for measurement, testing and analysis of body fluids; medical diagnostic apparatus for testing DNA; medical apparatus for diagnosis, detection and treatment of ocular disorders; medical apparatus for detection and diagnosis of mental health disorders; medical apparatus for treatment of metabolic disorders; medical apparatus for detection, diagnosis and treatment of neurological disorders; scientific instruments and apparatus, namely, scientific instruments and apparatus for the detection of pathogens for laboratory and research use and scientific apparatus for chemical or biological analysis; medical imaging apparatus; medical devices for the prevention, diagnosis and treatment of diseases, namely, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, oncological and viral diseases and disorders; medical apparatus, namely, sleep sensors and detectors for the treatment of sleep apnea, treatment of airway issues, and prevention of snoring; medical apparatus, namely, sleep sensors and detectors for measuring and monitoring personal temperature and other biometric data comprised of monitoring sensors and displays used for medical diagnostic and treatment purposes; Wearable monitors used to measure biometric data for medical use; Wearable medical devices for use in treating or diagnosing diseases and disorders, namely, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, oncological and viral diseases and disorders | ACTIVE | — |
| 016 | Printed publications in the scientific and medical fields, namely, brochures, journals, reports, newsletters, booklets, magazines and teaching materials; printed educational materials in the medical, scientific and pharmaceutical fields | ACTIVE | — |
| 041 | Educational services in the medical, scientific and pharmaceutical fields, namely, conducting classes, conferences, seminars, and workshops and distribution of educational materials in connection therewith in printed and electronic format | ACTIVE | — |
| 042 | Providing online non-downloadable software for use in providing health care information; providing online non-downloadable software for use in capture and analysis services to improve patient care; medical research; scientific research; conducting clinical trials for others; research and development in the fields of medical and scientific diagnostic procedures and therapeutic treatments; medical laboratories; medical laboratory services; scientific laboratory services; scientific laboratory services, namely, laboratory services for clinical research; laboratory research, analysis and testing services in the fields of oncology, virology, metabolic disease, cardiovascular health, mental health, chemistry, drug development, genetic disorders, immunology, genomics, pharmaceuticals, and neurological disorders; laboratory services, namely, storage of chemicals, data, biological tissues, clinical samples and the testing of analytes, nucleotides, and biological functions, all for research purposes; genetic testing services for scientific research purposes in the fields of oncology, virology, metabolic disease, cardiovascular health, mental health, chemistry, drug development, genetic disorders, immunology, genomics, pharmaceuticals, and neurological disorders; design and development of medical devices; design and development of computer software; design, development and implementation of software; design and development of health data security and privacy software; providing medical and scientific research information in the field of pharmaceuticals; providing scientific information in the field of laboratory testing, clinical procedures, genetic testing, neurological testing; scientific research consulting in the field of genetics, oncology, cardiology, mental health, neurological disorders, immunology, and hereditary disorders; providing medical and scientific research information in the fields of science, pharmaceuticals and technology; providing scientific information in the field of science, medicine, pharmaceuticals and technology, namely, scientific research in the fields of oncology, metabolic disease, cardiovascular health, mental health, chemistry, drug development, genetic disorders, immunology, genomics, pharmaceuticals, and neurological disorders; providing scientific information, advice and consultancy in relation to health data security and privacy software, laboratory testing, and clinical trials; research, design and development of software, sensors and devices for the monitoring of sleep; providing temporary use of non-downloadable cloud-based computer software for collecting, processing, analyzing, transmitting, validating and displaying data in the medical, scientific and pharmaceutical fields; providing temporary use of non-downloadable cloud-based computer software for the monitoring of health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use with medical clinical trials; providing temporary use of non-downloadable cloud-based computer software used for collecting, storing, analyzing, processing and displaying surgical images, videos, procedures and other surgical data; providing temporary use of non-downloadable cloud-based computer software for data processing and analysis for use with medical clinical trials; providing temporary use of non-downloadable cloud-based computer software used to manage clinical trials | ACTIVE | — |
| 044 | Medical services; medical diagnostic testing, monitoring and reporting services; consulting services in the field of health and wellness; health assessment services; providing medical information, consultancy and advisory services; genetic testing for medical purposes; providing medical information to patients, doctors, and medical professionals in the field of genetics, oncology, cardiology, mental health, neurological disorders, immunology, and hereditary disorders; Medical testing for diagnostic or treatment purposes in the fields of oncology, virology, metabolic disease, cardiovascular health, mental health, chemistry, drug development, genetic disorders, immunology, genomics, pharmaceuticals, and neurological disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Verily Life Sciences LLC
- Other trademarks owned by Verily Life Sciences LLC
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named V
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 2, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 28, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 28, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 28, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 30, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 5, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 5, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 15, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 31, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 31, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 31, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 31, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 31, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 18, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 12, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 31, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 30, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 3, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 3, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 3, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2020 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 6, 2020 | NWAP | NEW APPLICATION ENTERED | — |